Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
24/08/2026 13:43
BRIEF-Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million Aug 24 (Reuters) - Jacobio Pharmaceuticals Group H1 net income attributable RMB 600.6 million.
- H1 revenue RMB 730.9 million
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan